Add BrightSurf on Google Email

Rice scientists develop ‘molecular magnifying glass’ to help identify diseases earlier

Researchers at Rice University have developed a 'molecular magnifying glass' that allows them to visualize subtle environmental changes in proteins, which can indicate the earliest stages of diseases such as Alzheimer's, Parkinson's and cancer. This tool provides real-time monitoring of protein microenvironment changes in living cells.

SourceRice University·JournalNature Chemical Biology·DateSep 12, 2025

Scientists reveal brain signaling that sets Parkinson’s disease apart from essential tremor

Scientists have discovered a distinct neurochemical signature that sets Parkinson's disease apart from essential tremor, two common movement disorders. In a new study published in Nature Communications, researchers identified unique chemical signaling patterns of dopamine and serotonin that distinguish these conditions.

SourceVirginia Tech·JournalNature Communications·TypeExperimental study·DateSep 2, 2025

Why repetitive DNA has an active role in the human brain

Researchers at Lund University found that specific sequences within non-coding genome help shape the developing human brain. Disrupting these sequences leads to abnormalities in gene activity and brain organoid growth, highlighting their importance in regulating genes and development.

SourceLund University·JournalCell Genomics·TypeExperimental study·DateAug 25, 2025

Weekly injection could be life changing for Parkinson’s patients

Scientists at University of South Australia developed a long-acting injectable formulation that delivers levodopa and carbidopa over a week, reducing the need for multiple daily tablets. The biodegradable formulation improves treatment outcomes and patient compliance, offering a potential game-changer for Parkinson's care.

SourceUniversity of South Australia·JournalDrug Delivery and Translational Research·TypeExperimental study·DateJul 13, 2025

Non-invasive vagus nerve stimulation for the treatment of neurological and psychiatric disorders

Non-invasive vagus nerve stimulation (nVNS) has demonstrated efficacy in reducing seizure frequency, improving mood, and enhancing motor recovery in various conditions. Future research should prioritize standardized protocols, large-scale trials, and biomarker development to personalize treatment.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateJul 7, 2025

Targeting newly-identified brain protein brings hope of new treatment for Parkinson's disease

Researchers at the University of Sydney have identified a new brain protein involved in Parkinson's disease and found that targeting it with a drug treatment improved motor function in experimental models. The study suggests that this approach could slow or stop the progression of Parkinson's disease in humans.

SourceUniversity of Sydney·JournalActa Neuropathologica Communications·TypeExperimental study·DateJun 25, 2025

New study uncovers brain damage progression in Alzheimer's disease

Researchers analyzed single-cell transcriptomes from early, middle, and late stages of AD to identify subtle shifts in cellular activity. They found that mitochondria in vulnerable brain areas began to fail early in the disease, even before amyloid plaque buildup. The study also identified a gene called MEG3 involved in regulating mito...

SourceBGI Genomics·JournalProtein & Cell·DateJun 25, 2025

A new timeline for Parkinson's disease

Researchers at La Jolla Institute for Immunology discovered that T cell reactivity is highest during the prodromal period in Parkinson's disease, which can last for decades before noticeable symptoms. This finding may guide the development of early diagnostic tools and provide a new timeline for Parkinson's disease detection.

SourceLa Jolla Institute for Immunology·Journalnpj Parkinson s Disease·TypeExperimental study·DateJun 18, 2025

Autism linked to elevated risk of Parkinson’s disease

A large-scale study from Karolinska Institutet reports that individuals with an autism diagnosis are four times more likely to develop early-onset Parkinson's disease. The researchers believe that shared underlying biological mechanisms may be at play, particularly involving the neurotransmitter dopamine.

SourceKarolinska Institutet·JournalJAMA Neurology·TypeObservational study·DateMay 28, 2025

A groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases

Davis Joseph's groundbreaking discovery identifies a common master switch that can cure multiple brain-related diseases with a single method. The unified theory establishes that regulating axon-based 4E-BP2 protein deamidation can control disease progression.

SourceFLOGEN Star Outreach·JournalInternational Journal of Molecular Sciences·TypeSystematic review·DateMay 19, 2025

Scientists discover new way the brain learns

Researchers identified a dual learning system in the brain that enables habits to form and provides a scientific basis for breaking bad habits. The study suggests that replacing an action consistently can lead to the APE system forming a new habit, offering a potential strategy for overcoming addictions.

SourceSainsbury Wellcome Centre·JournalNature·TypeExperimental study·DateMay 14, 2025

Mass General Brigham researchers pinpoint ‘sweet spot’ for focused ultrasound to provide essential tremor relief

Researchers at Mass General Brigham have pinpointed a 'sweet spot' for focused ultrasound treatment to provide significant relief from essential tremor. The study identified a specific subregion of the brain's thalamus that can result in optimal and long-lasting tremor improvements while reducing side effects. With this breakthrough, p...

SourceMass General Brigham·JournalScience Advances·TypeObservational study·DateMay 14, 2025

The hope for detecting Parkinson’s disease much earlier with a simple brain scan

A team of researchers has shown that it may be possible to diagnose Parkinson's disease years before it becomes untreatable by scanning people's brains with fMRI. The study used ultra-high field experimental MRI scanners and analyzed brain activity in response to sensory impairments such as loss of smell and visual deficits.

SourceChampalimaud Centre for the Unknown·JournalJournal of Cerebral Blood Flow & Metabolism·TypeExperimental study·DateMay 7, 2025

Editing Parkinson's Disease – KAIST makes world's first discovery of an inflammatory RNA editing enzyme​

Researchers at KAIST have identified a key mechanism behind neuroinflammatory responses in Parkinson's disease, which is regulated by an RNA editing enzyme called ADAR1. This discovery suggests that targeting this enzyme could serve as a novel therapeutic strategy for treating the disease.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalScience Advances·TypeExperimental study·DateMay 2, 2025

Detecting Parkinson's disease with a simple retinal exam

Researchers from Université Laval discovered a non-invasive retinal exam can detect Parkinson's disease biomarkers, offering early diagnosis and potential intervention. The study found distinct retinal responses to light stimuli in people with Parkinson's compared to healthy individuals.

SourceUniversité Laval·JournalNeurobiology of Disease·TypeExperimental study·DateMay 1, 2025

New insight into how the brain switches gears could help Parkinson’s patients

Researchers discovered that the brain suppresses the current action without using another mechanism to inhibit it, enabling seamless transitions between actions. This finding could lead to the development of biologically-inspired robotic systems and improve clinical treatments for Parkinson's patients.

SourceUniversity of Southern California·JournalPLOS Computational Biology·TypeObservational study·DateApr 28, 2025